Drug Discovery

With the rise of GLP-1 agonists for weight management, the real-world patient experience often diverges from the neat narratives of clinical trials. To explore this complex landscape, we are speaking with biopharma expert Ivan Kairatov. Drawing on a recent analysis of hundreds of online user

For decades, the path to finding effective treatments for Alzheimer's disease has been fraught with frustratingly slow progress and a high rate of clinical failures, leaving millions of patients and their families with limited options. This long and challenging journey, however, is now reaching a

In a landmark development for the field of oncology, cancer researchers have uncovered a crucial molecular switch that has long been hampering the immune system's capacity to effectively fight tumors, presenting a new avenue of hope for countless patients who find no benefit in existing

The single greatest risk factor for developing Parkinson's disease has been systematically overlooked in the very laboratories dedicated to finding a cure, a baffling disconnect that a global consortium of scientists is now moving urgently to correct. For decades, the relentless march toward

The landscape of hematology is undergoing a significant transformation, driven by a new consensus that seeks to correct decades of suboptimal outcomes for a frequently overlooked demographic caught between two distinct worlds of medical care. For years, adolescents and young adults (AYAs) diagnosed

For decades, cancers driven by RAS gene mutations have posed one of the most formidable challenges in oncology, with these mutations being among the most common drivers of human cancers yet notoriously difficult to target with therapeutic agents. In a significant development that offers new hope